Cargando…
Opioid use does not limit potent low-dose HIV-1 latency reversal agent boosting
The combined effects of the HIV-1 and opioid epidemics on virus reservoir dynamics are less well characterized. To assess the impact of opioid use on HIV-1 latency reversal, we studied forty-seven suppressed participants with HIV-1 and observed that lower concentrations of combination latency revers...
Autores principales: | Lilie, Tyler, Bouzy, Jennifer, Asundi, Archana, Taylor, Jessica, Roche, Samantha, Olson, Alex, Coxen, Kendyll, Corry, Heather, Jordan, Hannah, Clayton, Kiera, Lin, Nina, Tsibris, Athe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10312897/ https://www.ncbi.nlm.nih.gov/pubmed/37398278 http://dx.doi.org/10.1101/2023.05.26.23290576 |
Ejemplares similares
-
Leveraging Novel Integrated Single-Cell Analyses to Define HIV-1 Latency Reversal
por: Zhao, Suhui, et al.
Publicado: (2021) -
Barriers to a cure for HIV in women
por: Gianella, Sara, et al.
Publicado: (2016) -
Increased Prevalence of Myocardial Injury in Patients with SARS-CoV-2 Viremia
por: Siddiqi, Hasan K., et al.
Publicado: (2021) -
SARS-CoV-2 viral load is associated with increased disease severity and mortality
por: Fajnzylber, Jesse, et al.
Publicado: (2020) -
Liver Fibrosis Index FIB‐4 Is Associated With Mortality in COVID‐19
por: Li, Yijia, et al.
Publicado: (2020)